review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Yunsuk Koh | |
Jonathan Jaoude | |||
P2860 | cites work | Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association | Q22241921 |
The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family | Q24557562 | ||
Collagenolytic activity in amphibian tissues: a tissue culture assay | Q24648397 | ||
Matrix metalloproteinases | Q28140451 | ||
Human and mouse proteases: a comparative genomic approach | Q28184208 | ||
Down-regulation of matrix metalloproteinase-9 expression by nitric oxide in lipopolysaccharide-stimulated rat primary astrocytes | Q28564519 | ||
Dynamics of fat cell turnover in humans | Q29615688 | ||
Matrix metalloproteinases: a tail of a frog that became a prince | Q33337157 | ||
Endurance exercise activates matrix metalloproteinases in human skeletal muscle | Q33398469 | ||
Aerobic exercise training reduces arterial stiffness in metabolic syndrome | Q33708165 | ||
Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck. | Q33758871 | ||
Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries | Q34098485 | ||
A bout of treadmill exercise increases matrix metalloproteinase-9 activity in the rat hippocampus | Q48247255 | ||
Human cardiac fibroblast extracellular matrix remodeling: dual effects of tissue inhibitor of metalloproteinase-2. | Q51066371 | ||
Exercise attenuates matrix metalloproteinase activity in preexisting atherosclerotic plaque. | Q53437555 | ||
TGF-β1 and TIMP-4 regulate atrial fibrosis in atrial fibrillation secondary to rheumatic heart disease. | Q53508778 | ||
Expression of matrix metalloproteinase-1 mRNA in peripheral blood mononuclear cells of systemic lupus erythematosus patients and its relationship with atherosclerosis. | Q54452305 | ||
C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: implications for clinical and subclinical atherosclerosis. | Q54610913 | ||
A single bout of exercise activates matrix metalloproteinase in human skeletal muscle | Q57607640 | ||
Crystal structures of the catalytic domain of human stromelysin-1 (MMP-3) and collagenase-3 (MMP-13) with a hydroxamic acid inhibitor SM-25453 | Q58006904 | ||
Acute eccentric resistance exercise decreases matrix metalloproteinase activity in obese elderly women | Q58884860 | ||
Interstitial Collagenase (MMP-1) Expression in Human Carotid Atherosclerosis | Q72034087 | ||
Influence of homocysteine on matrix metalloproteinase-2: activation and activity | Q73004122 | ||
Effect of MMP-2 deficiency on atherosclerotic lesion formation in apoE-deficient mice | Q82928035 | ||
Increased neointimal formation in cystathionine gamma-lyase deficient mice: role of hydrogen sulfide in α5β1-integrin and matrix metalloproteinase-2 expression in smooth muscle cells | Q83139435 | ||
The effect of a hydroxamic acid-containing polymer on active matrix metalloproteinases | Q83193877 | ||
Cardiovascular effects of exercise training: molecular mechanisms | Q85056820 | ||
Exercise-induced regulation of matrix metalloproteinases in the skeletal muscle of subjects with type 2 diabetes | Q88026897 | ||
Exhaustive exercise with different rest periods changes the collagen content and MMP-2 activation on the calcaneal tendon | Q95500525 | ||
Human skin collagenase. Isolation and mechanism of attack on the collagen molecule | Q34225093 | ||
Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques | Q34327535 | ||
Localizing matrix metalloproteinase activities in the pericellular environment | Q34418625 | ||
Exercise training reduces fibrosis and matrix metalloproteinase dysregulation in the aging rat heart | Q34592384 | ||
Genetic variants associated with circulating MMP1 levels near matrix metalloproteinase genes on chromosome 11q21-22 in Taiwanese: interaction with obesity. | Q34623513 | ||
Hydrogen sulfide mitigates transition from compensatory hypertrophy to heart failure | Q34785035 | ||
Progression of kidney disease in non-diabetic patients with coronary artery disease: predictive role of circulating matrix metalloproteinase-2, -3, and -9 | Q34906086 | ||
3-Deazaadenosine mitigates arterial remodeling and hypertension in hyperhomocysteinemic mice | Q35238627 | ||
Cardioprotective effects of voluntary exercise in a rat model: role of matrix metalloproteinase-2. | Q35271707 | ||
Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms. | Q35761393 | ||
Matrix metalloproteinases in neuromuscular disease | Q36780896 | ||
Gelatinases impart susceptibility to high-fat diet-induced obesity in mice | Q37010259 | ||
Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease | Q37313883 | ||
Tissue inhibitor of metalloproteinases-4. The road less traveled. | Q37331834 | ||
MMP-1 serum levels predict coronary atherosclerosis in humans | Q37368559 | ||
Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss | Q37491629 | ||
Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix | Q37573155 | ||
Resistance training improves body composition and increases matrix metalloproteinase 2 activity in biceps and gastrocnemius muscles of diet-induced obese rats | Q37676886 | ||
Matrix metalloproteinases in atherothrombosis. | Q37708600 | ||
Matrix metalloproteinases in metabolic syndrome | Q37979368 | ||
The response of matrix metalloproteinase-9 and -2 to exercise | Q38253992 | ||
Resistance training may concomitantly benefit body composition, blood pressure and muscle MMP-2 activity on the left ventricle of high-fat fed diet rats. | Q38314664 | ||
Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation | Q38358677 | ||
Regulation of matrix metalloproteinase-2 (MMP-2) activity by phosphorylation | Q40145612 | ||
Contrasting Inflammation Resolution during Atherosclerosis and Post Myocardial Infarction at the Level of Monocyte/Macrophage Phagocytic Clearance | Q42144621 | ||
Plaque rupture is a determinant of vascular events in carotid artery atherosclerotic disease: involvement of matrix metalloproteinases 2 and 9. | Q42790003 | ||
Hydrogen sulfide protects against vascular remodeling from endothelial damage | Q43115242 | ||
Prevention of abdominal aortic aneurysm progression by targeted inhibition of matrix metalloproteinase activity with batimastat-loaded nanoparticles | Q43184438 | ||
Hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis. | Q43540216 | ||
Fertilization defects in sperm from mice lacking fertilin beta. | Q44471252 | ||
Inhibition of inducible nitric oxide synthase and superoxide production reduces matrix metalloproteinase-9 activity and restores coronary vasomotor function in rat cardiac allografts | Q45008785 | ||
Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness | Q45158439 | ||
Expression of the tissue inhibitor of metalloproteinase-3 by transplanted VSMCs modifies heart structure and function after myocardial infarction. | Q45864109 | ||
Increased serum levels of tissue inhibitor of metalloproteinase-1 in patients with acute myocardial infarction. | Q45927352 | ||
A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. | Q45982189 | ||
Phase I trial of the matrix metalloproteinase inhibitor marimastat combined with carboplatin and paclitaxel in patients with advanced non-small cell lung cancer | Q46469006 | ||
Matrix metalloproteinase-1 promoter is associated with body mass index in Korean population with aged greater or equal to 50 years | Q46500547 | ||
Inhibiting matrix metalloproteinase-2 reduces protein release into coronary effluent from isolated rat hearts during ischemia-reperfusion | Q46567867 | ||
Regulation of homocysteine-induced MMP-9 by ERK1/2 pathway | Q46776194 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial | Q6936496 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | enzyme | Q8047 |
obesity | Q12174 | ||
peptide | Q172847 | ||
physical exercise | Q219067 | ||
physiological phenomenon | Q66615932 | ||
body size | Q66711810 | ||
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P304 | page(s) | 287-95 | |
P577 | publication date | 2016-07-14 | |
P1433 | published in | Vascular Health and Risk Management | Q7916443 |
P1476 | title | Matrix metalloproteinases in exercise and obesity | |
P478 | volume | 12 |
Q53691439 | Effect of Resistance Training on Extracellular Matrix Adaptations in Skeletal Muscle of Older Rats. |
Q90567494 | Effect of a Very-Low-Calorie Ketogenic Diet on Circulating Myokine Levels Compared with the Effect of Bariatric Surgery or a Low-Calorie Diet in Patients with Obesity |
Q92341061 | Effects of exercise training on markers of adipose tissue remodeling in patients with coronary artery disease and type 2 diabetes mellitus: sub study of the randomized controlled EXCADI trial |
Q39031756 | Emerging drugs for the treatment of obesity. |
Q64986265 | Intraoperative immunomodulatory effects of sevoflurane versus total intravenous anesthesia with propofol in bariatric surgery (the OBESITA trial): study protocol for a randomized controlled pilot trial. |
Q90441689 | MMP-2 and MMP-9 plasma levels are potential biomarkers for indeterminate and cardiac clinical forms progression in chronic Chagas disease |
Q50206277 | Regulation function of MMP-1 downregulated by siRNA on migration of heat-denatured dermal fibroblasts |
Q92188439 | Role of MicroRNAs in the Regulation of Subcutaneous White Adipose Tissue in Individuals With Obesity and Without Type 2 Diabetes |
Q99237762 | Therapeutic Efficacy of Antioxidants in Ameliorating Obesity Phenotype and Associated Comorbidities |
Q94581046 | Thermal stability of human matrix metalloproteinases |
Search more.